Orgenesis Announces Collaboration with Digilab to Develop Industrial 3D Printing Capability for Cellular Structures and Tissues for Clinical Use

Orgenesis Inc., a developer, manufacturer and service provider of advanced cell therapies, today announced that it has entered into a collaboration agreement with Digilab Inc. to develop a live cell printing process and systems designed to automate the production of three-dimensional live cellular structures and tissues.  Under the Agreement, Orgenesis will have the exclusive rights

Read More


In Situ Bioprinting of Autologous Skin Cells Accelerates Wound Healing of Extensive Excisional Full-Thickness Wounds

01 March 2019 P.M.Fornasari While the advent of 3D printers is commonly thought of as a revolution for manufacturing, it could have huge benefits for medicine as well. To help patch up large wounds that might normally require a skin graft, researchers at Wake Forest Institute for Regenerative Medicine (WFIRM) have developed a new bioprinter

Read More


Procter & Gamble Partners with Aether to Advance AI-Driven 3D Bioprinting

The 3D printing and AI startup Aether has reached a two-year joint agreement with Procter & Gamble to further develop its AI-driven 3D bioprinting system into an “intelligent robotic craftsman”. Procter & Gamble, the multinational consumer goods giant, has agreed to a two-year developmental agreement with the San Francisco-based 3D printing and AI startup Aether.

Read More